Genetic drivers of myeloproliferative diseases revealed – WEHI
24 January 2020 Dr Melissa Call, Associate Professor Matthew Call, and Dr Jessica Bridgford led the study at the Walter and Eliza Hall Institute. Institute scientists have revealed seven new genetic mutations that cause myeloproliferative diseases – chronic…
One step closer to understanding cancer-fighting immune cells
23 January 2020 Researchers discover that protective immune cells are not created equally This article first appeared in Science in Public. Personalised treatment of cancers has moved one step closer, thanks to University of Melbourne researcher Dr Susan Christo. Increasingly,…
Melbourne start-up Navi Medical Technologies receives $400,000 through Accelerating Commercialisation grant to develop pediatric medical device
30 January 2020 Navi Medical Technologies, a Melbourne based start-up company with ambitions to help critically ill newborns, has recently been awarded $396,452 in funding according to a recent media announcement from The Hon Karen Andrews MP, the Minister for Industry, Science…
Melbourne – A Heartland City in a New Decade
30 January 2020 Poised for Rockstar status as a Science & Technology Biomedical cluster Every year the Global Innovation Index ranks the innovation performance of around 130 economies globally. The picture from the Global Innovation Index reflects that…
Adoption and Diffusion of Disruptive Technologies:The Case of 3D Printing in the Medical Device Industry
28 January 2020 Australia has hosted several innovations in the 3D printed medical device industry, however widespread adoption and diffusion is quite low. This two-year project, funded by RMIT University provides analysis of the industry, its stakeholders (i.e. surgeons, patients,…
Importance of acceptable use policy – IT Systems & Services
28 January 2020 An acceptable use policy (AUP) is a document stipulating constraints and practices that a user must agree to for access to a corporate network or the Internet. Many businesses and educational facilities require that employees…
First product order from PMI and first patient treated in Germany
22 January 2020 PolyNovo has received its first orders of BTM from PMI for use in Germany, Austria and Switzerland. The first orders for NovoSorb BTM were shipped to hospitals in preparation for the first surgery. PolyNovo is…
MTPConnect – Introducing Dr David Fox – Senior Director Sustainability
21 January 2020 MTPConnect is excited to announce the appointment of Dr David Fox as Senior Director of Sustainability starting today. David will be based in Newcastle, NSW and will work with Managing Director & CEO Dr Dan…
Business, Sport Back New Drive To Support Fire-Affected Communities
20 January 2020 The Victorian Government has released details of a new initiative that will see more than 115 major organisations hold multi-day stays in bushfire affected areas in regional Victoria. Premier Daniel Andrews and Minister for Tourism,…
Bionic Vision Technologies Announces Interim Pilot Study Results of the BVT Bionic Eye System Designed to Help the Blind Achieve Greater Mobility and Independence
13 January 2020 Up to 44-Week Data Shows Significant Improvement in Both Obstacle Awareness and Object Detection Bionic Vision Technologies today announced the interim results of a pilot study involving four patients with late-stage Retinitis Pigmentosa (RP) implanted…
Two Million Dollar Month – PolyNovo Limited
7 January 2020 PolyNovo has said previously that it does not intend to issue quarterly financial statements. However, the Company would like to give shareholders a sense of the ramp up and direction of sales. Accordingly, we inform…
Gilead Sciences Announces the Appointment of Belinda Wood as new Senior Director of Government Affairs For Australia & NZ
13 January 2020 Gilead Sciences today announced the appointment of Belinda Wood as the new Senior Director of Government Affairs for Gilead Sciences in Australia and New Zealand (ANZ). In this role, Ms Wood will be responsible for…
